Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neurocrine Biosciences Inc (NASDAQ:NBIX)

49.56
Delayed Data
As of Aug 04
 +0.57 / +1.16%
Today’s Change
13.20
Today|||52-Week Range
56.18
+121.84%
Year-to-Date

Today’s Trading

Previous close48.99
Today’s open48.81
Day’s range48.49 - 49.71
Volume544,085
Average volume (3 months)874,636
Market cap$4.3B
Dividend yield--
Data as of 08/04/2015

Growth & Valuation

Earnings growth (last year)-17.39%
Earnings growth (this year)-3.24%
Earnings growth (next 5 years)-9.18%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book18.36

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA-0.28-0.85%
RAREUltragenyx Pharmaceu...-1.31-1.11%
ACADACADIA Pharmaceutica...-0.49-1.02%
IPXLImpax Laboratories I...+0.25+0.52%
Data as of 08/04/2015

Financials

Next reporting dateOctober 28, 2015
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$0.00
Annual profit (last year)-$60.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Kevin Charles Gorman
Vice President-Information Technology &
Operations
Bill Wilson
Corporate headquarters
San Diego, California

Forecasts